LIPID METABOLISM CORRECTION BY ANTISENSE TECHNOLOGY
Antisense oligonucleotides (ASO) technology in elaboration of drugs for lipid metabolism correction is discussed. The main ASO types and modes of its action on the target mRNA are analyzed. Advantages and disadvantages of different ASO are considered in the context of requirements for their therapeu...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2015-09-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/229 |